The U.S. plans to distribute 80 million doses around the world this month – with India and South Korea tapped as early recipients.
The United States will donate 75 percent of its unused COVID-19 vaccines to the U.N.-backed COVAX global vaccine sharing program, President Joe Biden announced Thursday.
The White House unveiled the allocation for sharing the first 25 million doses with the world. The U.S. has said it plans to share 80 million vaccine doses globally by the end of June. The administration says 25 percent will be kept in reserve for emergencies and for the U.S. to share directly with allies and partners.
“As long as this pandemic is raging anywhere in the world, the American people will still be vulnerable,” Biden said in a statement. “And the United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home.”
Of the first tranche of 25 million doses, the White House says about 19 million will go to COVAX, with approximately 6 million for South and Central America, 7 million for Asia, and 5 million for Africa. The doses mark a substantial — and immediate — boost to the lagging COVAX effort, which to date has shared just 76 million doses with needy countries.
U.S. National Security Adviser Jake Sullivan said the U.S. “will retain the say in terms of where” the doses distributed through COVAX ultimately go.
“We’re not seeking to extract concessions, we’re not extorting, we’re not imposing conditions the way that other countries who are providing doses are doing; we’re doing none of those things,” said Sullivan. “These are doses that are being given, donated free and clear to these countries, for the sole purpose of improving the public health situation and helping end the pandemic.”
According to a White House fact sheet, for doses shared through COVAX, “the United States will prioritize Latin America and the Caribbean, South and Southeast Asia, and Africa, in coordination with the African Union.” In Asia specifically, the United States’ COVAX-distributed doses will go to Afghanistan, Bangladesh, India, Indonesia, Laos, Maldives, Malaysia, Nepal, Pakistan, Papua New Guinea, the Philippines, Sri Lanka, Taiwan, Thailand, and Vietnam, as well as the Pacific Islands.
Diplomat Brief Weekly Newsletter N Get briefed on the story of the week, and developing stories to watch across the Asia-Pacific. Get the Newsletter
The remaining 6 million will be directed by the White House to U.S. allies and partners, including Mexico, Canada, and the Republic of Korea, West Bank and Gaza, India, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq, and Yemen, as well as for United Nations frontline workers.
The growing U.S. stockpile of COVID-19 vaccines is seen as a testament not only to American ingenuity, but also to its global privilege. The long-awaited vaccine sharing plan comes as demand for shots in the United States has dropped significantly, as more than 63 percent of adults have received at least one dose, and as global inequities in supply have become more glaring.
Scores of countries have requested doses from the United States, but to date only Mexico and Canada have received a combined 4.5 million doses. The U.S. also has announced plans to share enough shots with South Korea to vaccinate its 550,000 troops who serve alongside American service members on the peninsula. White House COVID-19 coordinator Jeff Zients said that 1 million Johnson & Johnson doses were being shipped to South Korea Thursday.
Biden has committed to providing other nations with all 60 million domestically produced doses of the AstraZeneca vaccine. That vaccine has yet to be authorized for use in the U.S. but is widely approved around the world. The U.S.-produced doses will be available to ship as soon as they clear a safety review by the Food and Drug Administration.
The White House says the initial 25 million doses will be shipped from existing production of Pfizer, Moderna, and Johnson & Johnson vaccine stocks. Even more doses are expected to be made available to share in the months ahead.
As part of its purchase agreements with drug manufacturers, the U.S. controlled the initial production by its domestic manufacturers. Pfizer and Moderna are only now starting to export vaccines produced in the U.S. to overseas customers. The U.S. has hundreds of millions more doses on order, both of authorized and in-development vaccines.
The White House also announced Thursday that it is lifting restrictions on sharing vaccines produced by AstraZeneca, as well as Sanofi and Novavax, which are also not authorized in the U.S., allowing the companies to determine themselves where to share their doses.